Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?

dc.contributor.author

Grunhut, Joel

dc.contributor.author

Wang, Wei

dc.contributor.author

Aykut, Berk

dc.contributor.author

Gakhal, Inderdeep

dc.contributor.author

Torres-Hernandez, Alejandro

dc.contributor.author

Miller, George

dc.date.accessioned

2024-02-23T21:03:34Z

dc.date.available

2024-02-23T21:03:34Z

dc.description.abstract

<jats:p>Nonalcoholic steatohepatitis (NASH) is a subtype of nonalcoholic fatty liver disease that is characterised by steatosis, chronic inflammation, and hepatocellular injury with or without fibrosis. The role and activation of macrophages in the pathogenesis of NASH is complex and is being studied for possible therapeutic options to help the millions of people diagnosed with the disease. The purpose of this review is to discuss the pathogenesis of NASH through the activation and role of Kupffer cells and other macrophages in causing inflammation and progression of NASH. Furthermore, this review aims to outline some of the current therapeutic options targeting the pathogenesis of NASH.</jats:p>

dc.identifier.issn

2053-4221

dc.identifier.uri

https://hdl.handle.net/10161/30188

dc.publisher

European Medical Group

dc.relation.ispartof

EMJ Hepatology

dc.relation.isversionof

10.33590/emjhepatol/10312252

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.title

Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?

dc.type

Journal article

duke.contributor.orcid

Aykut, Berk|0000-0001-8343-4258

pubs.begin-page

100

pubs.end-page

109

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Staff

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Surgery

pubs.publication-status

Published online

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MacrophagesNASH_EMJ_2018.pdf
Size:
629.88 KB
Format:
Adobe Portable Document Format
Description:
Published version